PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson’s Disease

Parkinson’s disease (PD) is characterized mainly by the loss of dopaminergic neurons in the substantia nigra (SN) mediated via oxidative stress. Although glutaredoxin-1 (GLRX1) is known as one of the antioxidants involved in cell survival, the effects of GLRX1 on PD are still unclear. In this study,...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Molecules
Päätekijät: Choi, Yeon Joo, Kim, Dae Won, Shin, Min Jea, Yeo, Hyeon Ji, Yeo, Eun Ji, Lee, Lee Re, Song, Yejin, Kim, Duk-Soo, Han, Kyu Hyung, Park, Jinseu, Lee, Keun Wook, Park, Jong Kook, Eum, Won Sik, Choi, Soo Young
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8198499/
https://ncbi.nlm.nih.gov/pubmed/34206041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules26113329
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia